SynopsisSevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceutica.....
SynopsisTeicoplanin is an antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. It is a semisynthetic glycopeptide antibiotic with a spe.....
SynopsisMRSA is the result of decades of often unnecessary antibiotic use. For years, antibiotics have been prescribed for colds, flu and other viral infections that don't respond to these drugs. The global MRSA Antibiotics market was valued at US$ 4055.6 millio.....
SynopsisRaltegravir (RAL), sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. The global Raltegravir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 20.....
SynopsisFamciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections. The global Famciclovir market was value.....
SynopsisClindamycin phosphate for Vaginal is used for the treatment of non-pregnant women ≥ 18 years of age with bacterial vaginosis. The global Clindamycin Phosphate for Vaginal market was valued at US$ 142 million in 2023 and is anticipated to reach US$ 218.3 .....
SynopsisA coccidiostat is an antiprotozoal agent that acts upon Coccidia parasites. The global Coccidiostat market was valued at US$ 387 million in 2023 and is anticipated to reach US$ 572.4 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2.....
SynopsisSingle channel pipettes typically dispense between 0 to 2500 ul volumes, and are available in two formats: adjustable or fixed volume. The global Single Channel Pipettes market was valued at US$ 642 million in 2023 and is anticipated to reach US$ 925.7 m.....
Bilirubin (formerly referred to as haematoidin and discovered by Rudolf Virchow in 1847) is a yellow compound that occurs in the normal catabolic pathway that breaks down heme in vertebrates. This catabolism is a necessary process in the body's clearance of waste products .....
SynopsisGlobal Artificial Dermal Repair Materials market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key manufacturers engaged in the Artificial Dermal Repair Materials ind.....
